Početna › Generalizirani anksiozni poremećaj › Florida
Kliničke studije za Generalizirani anksiozni poremećaj u državi Florida
7 studija za Generalizirani anksiozni poremećaj traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
- Sunshine Medical Research Studies Inc, Miami
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07807865Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- Premier Clinical Research, Miami
- Global Medical Institutes, Miami
- Miami Dade Medical Research Institute, Miami
- i još 3
U tijeku regrutacijaFaza 2
Sve dobne skupine · Oba spola · Ažurirano 25. ruj 2026. · NCT06480383Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- Miami Dade Medical Research Institute, Miami
- University of South Florida, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06701903RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
- Innovative Clinical Research, Inc., Lauderhill
- University of South Florida, Tampa
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT07489651A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
- Sarkis Clinical Trials - Gainesville, Gainesville
- Clinical Neuroscience Solutions, LLC, Jacksonville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07759128A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
- Clinical Neuroscience Solutions Inc. (CNS) - Orlando, Orlando
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT07767903Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- Cns Healthcare - Jacksonville /ID# 268588, Jacksonville
- Accel Research Sites Network - St. Pete /ID# 267821, Largo
- K2 Medical Research, LLC /ID# 267841, Maitland
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 17. lip 2026. · NCT06846320Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.